Related Experiment Video
Updated: Jul 19, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Predictive risk factors for coronary artery abnormalities in Kawasaki disease
Taeyeun Kim1, Wooksun Choi, Chan-Wook Woo
1Department of Pediatrics, Korea University College of Medicine, Seoul, South Korea.
Insights
Kawasaki disease (KD) patients with prolonged fever exceeding 8 days are at higher risk for coronary artery abnormalities (CAA). Early identification of intravenous gamma-globulin (IVGG) non-responders is crucial for preventing CAA in KD.
Area of Science:
- Pediatrics
- Cardiology
- Infectious Diseases
Background:
- Kawasaki disease (KD) is a leading cause of acquired heart disease in children.
- Coronary artery abnormalities (CAA) are a serious complication of KD.
- Predicting CAA development is essential for timely intervention.
Purpose of the Study:
- To identify clinical characteristics that predict the development of CAA in patients with KD.
- To assess the association between fever duration, IVGG response, and CAA incidence.
Main Methods:
- Retrospective review of medical records of 285 KD patients.
- Analysis of clinical data including fever duration, IVGG response, and laboratory markers.
- Multivariate regression analysis to identify significant predictors of CAA.
Main Results:
- 19 out of 285 KD patients (6.7%) developed CAA.
- Patients with CAA showed longer fever duration after IVGG and higher CRP levels.
- Prolonged fever (over 8 days total) was the most significant predictor of CAA (OR=4.052).
- IVGG non-responders had a higher incidence of CAA and prolonged fever post-treatment.
Conclusions:
- Total fever duration exceeding 8 days is a critical predictor of CAA in KD.
- Early identification of IVGG non-responders and prompt fever management can reduce CAA incidence.
- Close monitoring and aggressive treatment strategies are vital for KD patients at high risk for CAA.
Abstract:
Clinical characteristics to predict the development of coronary artery abnormalities (CAA) in Kawasaki disease (KD) were assessed by reviewing medical records of patients diagnosed with KD at Korea University Medical Center from March 2001 to February 2005. Of the 285 patients diagnosed with KD, 19 developed CAA (6.7%). Compared with the CAA(-) group, the CAA(+) group had a longer duration of fever after intravenous gamma-globulin (IVGG) injection (2.4+/-2.9 vs. 1.5+/-1.2 days, p=0.008) and higher C-reactive protein (CRP)(12.3+/-7.8 vs. 8.7+/-7.1 mg/dL, p=0.038). In particular, the CAA(+) group tended to have more than 7 days of fever before IVGG and more than 3 days of fever after IVGG (26.3 vs. 5.3%, p<0.001; 26.3 vs. 6.4%, p=0.002). When the IVGG responsiveness was defined by the presence of defervescence within 3 days after IVGG, IVGG-non-responders showed a higher incidence of CAA (22.7 vs. 5.3%, p=0.002). Non-responders had a longer duration of fever after IVGG (5.5+/-1.9 vs. 1.2+/-0.6 days, p<0.001) and a significantly increased CRP, AST, ALT and total bilirubin. Multivariate regression analysis for CAA showed that the only factor significantly associated with the development of CAA was total fever that lasted for longer than 8 days (OR=4.052, 95% CI=1.151-14.263, p=0.0293). Conclusively, the most important predictor of CAA in KD is total duration of fever longer than 8 days. Early identification of IVGG non-responders and active therapeutic intervention for fever in KD cases might decrease the incidence of CAA.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies